- Home
- / Skye Bioscience
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Skye Bioscience financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.1
2021-03-19
Market Capitalization
$22.5 M
2021-03-19
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General and administrative expense | 28.5K | 2.5M | 3.7M | 3.5M | 3.5M | 4.4M | 4.4M | 4.3M | 4.9M | 6.1M | 7.9M | 17.7M | 15.8M |
| Operating expense total | 28.5K | 2.7M | 4.3M | 4.5M | 3.9M | 4.7M | 6.6M | 6.3M | 12.1M | 36.4M | 58.2M | ||
| EBIT | (7.2K) | (2.7M) | (4.3M) | (4.5M) | (3.9M) | (4.7M) | (6.6M) | (6.3M) | (7.8M) | (18.3M) | (34.7M) | (30.2M) | (58.2M) |
| Interest income | 789.0 | 100.0K | 3.0M | 1.9M | |||||||||
| Interest expense | 667.0 | 94.8K | 1.0M | 706.4K | 769.2K | 665.1K | 906.3K | 749.3K | |||||
| Pre tax profit | (3.8K) | (4.8M) | (3.2M) | (3.1M) | (19.2M) | 1.1M | (6.6M) | (8.5M) | (19.5M) | (37.6M) | (26.6M) | (55.9M) | |
| Income tax expense | 2.5K | 1.7K | 1.6K | 1.6K | 1.6K | 1.6K | 1.6K | 2.1K | 6.7K | 3.6K | 10.1K | 5.4K | |
| Net Income | (3.8K) | (2.7M) | (4.8M) | (3.2M) | (3.1M) | (19.2M) | 1.1M | (6.6M) | (8.5M) | (19.5M) | (37.6M) | (26.6M) | (55.9M) |
| EPS | 0.0 | (5.0) | (0.7) | (1.4) |